Your browser doesn't support javascript.
loading
Intravenous administration of allogeneic Wharton jelly-derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease.
Yang, Vicky K; Meola, Dawn M; Davis, Airiel; Barton, Bruce; Hoffman, Andrew M.
Am J Vet Res ; 82(6): 487-493, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34032485
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hematopoietic Stem Cell Transplantation / Dog Diseases / Wharton Jelly / Mesenchymal Stem Cells / Heart Failure Limits: Animals Language: En Journal: Am J Vet Res Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Hematopoietic Stem Cell Transplantation / Dog Diseases / Wharton Jelly / Mesenchymal Stem Cells / Heart Failure Limits: Animals Language: En Journal: Am J Vet Res Year: 2021 Document type: Article Country of publication: Estados Unidos